Skip to main content

Peer Review reports

From: Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial

Original Submission
28 Apr 2020 Submitted Original manuscript
22 Jun 2020 Reviewed Reviewer Report - Riaz Qureshi
5 Aug 2020 Author responded Author comments - John Castle
Resubmission - Version 2
5 Aug 2020 Submitted Manuscript version 2
11 Aug 2020 Reviewed Reviewer Report - Riaz Qureshi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Aug 2020 Editorially accepted
27 Aug 2020 Article published 10.1186/s13063-020-04675-7

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215